Latest Stocks: Zacks Investment Research Upgrades Health Insurance Innovations Inc (HIIQ) to Buy

Latest Stocks: Zacks Investment Research Upgrades Health Insurance Innovations Inc (HIIQ) to Buy

Health Insurance Innovations Inc (NASDAQ:HIIQ) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday. The brokerage presently has a $26.00 target price on the financial services provider’s stock. Zacks Investment Research‘s target price indicates a potential upside of 19.27% from the company’s previous close.

According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “

Several other brokerages also recently commented on HIIQ. TheStreet raised Health Insurance Innovations from a “c” rating to a “b-” rating in a research report on Monday, May 22nd. First Analysis assumed coverage on Health Insurance Innovations in a research report on Friday, March 3rd. They issued an “overweight” rating on the stock. Raymond James Financial, Inc. raised Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research report on Thursday, May 4th. Cantor Fitzgerald assumed coverage on Health Insurance Innovations in a research report on Thursday, March 30th. They issued an “overweight” rating and a $30.00 price target on the stock. Finally, Canaccord Genuity assumed coverage on Health Insurance Innovations in a research report on Monday, March 13th. They issued a “buy” rating and a $28.00 price target on the stock. Seven equities research analysts have rated the stock with a buy rating, Health Insurance Innovations has an average rating of “Buy” and a consensus price target of $24.80.

Shares of Health Insurance Innovations (NASDAQ HIIQ) opened at 21.80 on Friday. The stock’s 50 day moving average is $19.31 and its 200-day moving average is $17.21. The firm has a market cap of $257.61 million, a P/E ratio of 19.68 and a beta of 0.67. Health Insurance Innovations has a 52-week low of $3.72 and a 52-week high of $22.95. Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings results on Wednesday, May 3rd. The financial services provider reported $0.36 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.05. The company had revenue of $55.87 million for the quarter, compared to the consensus estimate of $54.18 million. Health Insurance Innovations had a return on equity of 16.47% and a net margin of 2.91%. Equities analysts anticipate that Health Insurance Innovations will post $1.44 earnings per share for the current fiscal year.

Shares of Health Insurance Innovations (NASDAQ HIIQ) opened at 21.80 on Friday. The stock’s 50 day moving average is $19.31 and its 200-day moving average is $17.21. The firm has a market cap of $257.61 million, a P/E ratio of 19.68 and a beta of 0.67. Health Insurance Innovations has a 52-week low of $3.72 and a 52-week high of $22.95. In other Health Insurance Innovations news, insider Michael W. Kosloske sold 3,000,000 shares of the company’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $13.16, for a total value of $39,480,000.00. Following the sale, the insider now directly owns 100 shares in the company, valued at $1,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sheldon Wang sold 7,560 shares of the company’s stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $16.77, for a total value of $126,781.20. Following the completion of the sale, the insider now owns 250,001 shares in the company, valued at $4,192,516.77. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 3,160,802 shares of company stock worth $42,503,116. 52.70% of the stock is currently owned by company insiders.

A number of hedge funds have recently made changes to their positions in the stock. AWM Investment Company Inc. bought a new stake in shares of Health Insurance Innovations during the third quarter worth $630,000. Cannell Capital LLC boosted its stake in shares of Health Insurance Innovations by 0.4% in the third quarter. Cannell Capital LLC now owns 1,174,962 shares of the financial services provider’s stock worth $6,169,000 after buying an additional 4,343 shares during the period. Cavalier Investments LLC bought a new stake in shares of Health Insurance Innovations during the fourth quarter worth $339,000. Renaissance Technologies LLC boosted its stake in shares of Health Insurance Innovations by 1,031.7% in the fourth quarter. Renaissance Technologies LLC now owns 213,900 shares of the financial services provider’s stock worth $3,818,000 after buying an additional 195,000 shares during the period. Finally, A.R.T. Advisors LLC bought a new stake in shares of Health Insurance Innovations during the fourth quarter worth $910,000. Hedge funds and other institutional investors own 23.18% of the company’s stock. About Health Insurance Innovations

Related posts

Leave a Comment